1. Home
  2. PYXS vs MLCI Comparison

PYXS vs MLCI Comparison

Compare PYXS & MLCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pyxis Oncology Inc.

PYXS

Pyxis Oncology Inc.

HOLD

Current Price

$1.31

Market Cap

71.6M

Sector

Health Care

ML Signal

HOLD

MLCI

Mount Logan Capital Inc.

N/A

Current Price

$3.49

Market Cap

69.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PYXS
MLCI
Founded
2018
N/A
Country
United States
United States
Employees
N/A
21
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
71.6M
69.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
PYXS
MLCI
Price
$1.31
$3.49
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
281.8K
70.8K
Earning Date
03-23-2026
03-13-2026
Dividend Yield
N/A
3.31%
EPS Growth
3.03
N/A
EPS
N/A
N/A
Revenue
$13,858,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.84
$3.55
52 Week High
$5.55
$8.68

Technical Indicators

Market Signals
Indicator
PYXS
MLCI
Relative Strength Index (RSI) 39.79 20.48
Support Level $1.29 N/A
Resistance Level $1.69 $8.06
Average True Range (ATR) 0.11 0.35
MACD -0.01 -0.11
Stochastic Oscillator 11.90 2.86

Price Performance

Historical Comparison
PYXS
MLCI

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

About MLCI Mount Logan Capital Inc.

Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The Company's reporting segments include asset management and insurance. The asset management segment reflects the Company's historical operations through its subsidiaries, including ML Management, and the insurance segment represents Ability's operations. The Company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The insurance business is operated by Ability. Ability's insurance business consists of premium revenue from long term care insurance policies.

Share on Social Networks: